Mecillinam did not increase the activity, minimum inhibitory concentration or minimum bactericidal concentration values, of 3-lactam compounds against streptococci, staphylococci, clostridia, listeria, or bacteroides. Synergy was not demonstrated with combinations of mecillinam and aminoglycosides (kanamycin, gentamicin, tobramycin, amikacin), chloramphenicol, tetracycline, or polymyxins.
The increasing incidence of resistance of members of the Enterobacteriaceae to penicillin, cephalosporins, and aminoglycoside antibiotics has prompted a search for agents that might overcome resistance through structural modification of the antimicrobial agent (14) . In 1972 Lund and Tybring (10) reported on the synthesis of a new class of penicillanic acid derivatives, the f8-amidinopenicillanic acids. One of these compounds, a 6,B-hexahydro-1-Hazepin-1-ly-methyleneamino penicillanic acid, mecillinam (formerly called FL 1060), was shown to be unusually active against certain gram-negative bacilli, particularly Escherichia coli (22) . Studies in several laboratories showed that mecillinam produced a swelling of bacteria so that they became spherical (12) . This was different from the morphological changes produced by benzylpenicillin or ampicillin. Park and Burman (17) noted that the mecillinam did not inhibit murein transpeptidase. James et al. (7) , using E. coli B/r in exponential and synchronous cultures, showed that mecillinam blocked an event occurring early in the cell cycle essential for normal cell elongation. Spratt (21) subsequently showed that mecillinam bound preferentially to one of the penicillin-binding proteins, namely, protein two, which is involved in the shape of bacilli, rather than to the proteins involved in elongation or septum formation.
These observations suggested to us that mecillinam might act in a synergistic manner with other f8-lactam compounds that act on the cell proteins that are involved with elongation or septum formation. We performed a systematic investigation of the combined antimicrobial activity of mecillinam with antibiotics that inhibit cell wall formation, those that bind to the bacterial cytoplasmic membrane, and those whose entry into the bacterial cell has been facilitated by previous exposure to penicillins.
( Pseudomonas aeruginosa. Synergy is present when 1 part of mecillinam is combined with 100 parts of carbenicillin but is not present when the reverse is done. Synergy was not usually present above the 10:1 ratio of mecillinam to other antibiotics, whereas it was seen at a 100:1 ratio of penicillin or cephalosporin to mecillinam. Of 17 organisms tested by this method, 13 were synergistically inhibited at a ratio of 100 parts of carbenicillin, amoxicillin, ampicillin, cephalothin, or cefoxitin to 1 part of mecillinam. Only one isolate was inhibited at a ratio of 100 parts of mecillinam to 1 part of the other agent. All were both inhibited and killed at a ratio of 5 parts of mecillinam to 1 part of the other agent. Optimal MBC values were obtained at a 5:1 or 1:1 ratio of drugs in combination with either agent in excess.
A plot of the combination of ampicillin and mecillinam tested in agar against 50 organisms is given in Fig. 4 . The x axis reflects the MIC of ampicillin alone, and the y axis reflects the ampicillin MIC in the presence of one-fourth the mecillinam MIC. The combination shows indifference for 13 organisms, partial synergy for four, and synergy for the remainder. Indolepositive Proteus (P. morganii, P. vulgaris) and S. marcescens were least likely to show synergy by this technique. All of these organisms had mecillinam MIC values >3.2 jig/ml.
Since I had previously shown that the marked difference between MIC and MBC values of mecillinam was in part due to destruction of the antibiotic by ,3-lactamase (13) , I combined mecillinam with cloxacillin. Table 5 shows that addition of cloxacillin could reduce the mecillinam MIC and MBC values against Table 7 was 1.6 ,ug/ml and the MBC, when combined with mecillinam, was 1.6 ug/ml. The same was true for the Listeria strains; the MBC was 12.5 ug/ml for amoxicillin alone and 12.5 ug/ml for amoxicillin combined with mecillinam. Of note was the fact that the ampicillin MIC with several enterococci was actually one tube or twofold greater when mecillinam was present. This was not a universal finding, however.
Although mecillinam showed synergy with all of the j8-lactam antibiotics tested, it did not show synergy when combined with aminoglycosides, chloramphenicol, polymyxin B, or clindamycin (Table 8) . Organisms susceptible and resistant to the aminoglycosides were tested. In only two instances was antagonism seen. This was with tetracycline and chloramphenicol in which cases the mecillinam MIC was increased.
The organisms susceptible to mecillinam (MIC, 0.4 ,ug), such as a kanamycin-resistant (MIC, 50 ,ug/ml) E. coli, had the same mecillinam MIC (0.4 Ag/ml). Effect of medium upon synergy. Previous work from my laboratory has shown the effect of osmolality and cation content on the mecillinam MIC (13) . I determined the effect of sodium and osmolality on synergy. The results are shown in Table 9 . In a medium of low conductivity (<6 mS), there is no demonstrable synergy when the MIC values are considered. However, if the MBC values are used, there is definite synergy. This was also true for the mecillinam-cephalothin combination when tested against Klebsiella strain 2557.
When studies of synergy were performed in nutrient broth with an inoculum of 104 colonyforming units or less, it was not possible to show synergy between mecillinam and ampicillin against most E. coli, K. pneumoniae, Citrobacter freundii, and E. cloacae, since their me- Previous studies of synergy have concentrated upon use of compounds that affect two points in a biochemical pathway, such as is seen with the trimethoprim-sulfamethoxazole combination (2) . Other approaches have involved a combination of antibiotics of the same class, in which one agent prevents the inactivation of the other antibiotic. This approach has been used with 13-lactam antibiotics such as ampicillin and cloxacillin (16, 19) . A third approach is that of combining carbenicillin and amino-glycosides to effect killing of Pseudomonas (3, 20) or combining cephalosporins with aminoglycosides to react against indole-positive Proteus (5) . The mechanism used to explain this synergy is the increased entry of the aminoglycoside to reach its receptor site.
The (3-amidinopenicillin mecillinam appeared not to inhibit murein transpeptidase (11) , but rather seemed to bind to a protein involved in cell elongation (7, 17, 21 (18) .
